Inhibition of mac-1 receptor binding to fibrinogen using d30...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/42 (2006.01) A61K 38/36 (2006.01) A61K 39/395 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/75 (2006.01) C12N 15/12 (2006.01) G01N 33/53 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2087169

2087169 9201464 PCTABS00010 The present invention contemplates therapeutic compositions containing a D30 homolog capable of binding to the Mac-1 receptor D30 binding site and inhibiting fibrinogen binding to the Mac-1 receptor via the D30 binding site. Methods of inhibiting Mac-1 receptor binding to any Mac-1 ligand and methods of inhibiting Mac-1 receptor mediated inflammation within a patient by administering a D30 homolog are also contemplated.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of mac-1 receptor binding to fibrinogen using d30... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of mac-1 receptor binding to fibrinogen using d30..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of mac-1 receptor binding to fibrinogen using d30... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1956707

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.